Proton pump inhibitors-induced psychiatric symptoms

被引:1
|
作者
Zhao, Li [1 ]
Xie, Dajiang [2 ]
机构
[1] Zhejiang Chinese Med Univ, Hangzhou Red Cross Hosp Integrated Tradit Chinese, Dept Gastroenterol, Hangzhou, Peoples R China
[2] Zhejiang Univ, Sir Run Run Shaw Hosp, Coll Med Sci, Dept Neurosurg, Hangzhou 310016, Peoples R China
关键词
Proton pump inhibitors; psychiatric symptoms; treatment; DELIRIUM; RABEPRAZOLE; THERAPY; RISK;
D O I
10.1080/13554794.2022.2138451
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Proton pump inhibitors are widely used in cure of digestive tract diseases and drug-induced psychiatric symptoms are rare. In this study, we aim to investigate the presentations, diagnostic approaches, treatments and prognosis. We present one case of proton pump inhibitors-induced motor hallucination underwent drug withdrawal and recovery subsequently. Delirium Rating Scale and Hamilton Anxiety Scale examinations showed transient delirium and anxiety. Proton pump inhibitors-induced psychiatric symptoms are benign and affect patients' prognosis. No standard treatment exists, and the strategies contain discontinuing proton pump inhibitors and/or antipsychotics drugs. Overall prognosis is usually good and recurrence seems to be rare.
引用
收藏
页码:415 / 418
页数:4
相关论文
共 50 条
  • [41] Are proton pump inhibitors really so dangerous?
    Savarino, Vincenzo
    Dulbecco, Pietro
    Savarino, Edoardo
    DIGESTIVE AND LIVER DISEASE, 2016, 48 (08) : 851 - 859
  • [42] What is the truth about proton pump inhibitors?
    Albarki, Hashm
    Pun, Amy
    Paddle, Paul M.
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2020, 28 (06) : 376 - 384
  • [43] Proton pump inhibitors: impact on glucose metabolism
    Boj-Carceller, Diana
    ENDOCRINE, 2013, 43 (01) : 22 - 32
  • [44] Proton pump inhibitors, bone and phosphocalcic metabolism
    Philippoteaux, Cecile
    Paccou, Julien
    Chazard, Emmanuel
    Cortet, Bernard
    JOINT BONE SPINE, 2024, 91 (05)
  • [45] Reducing Adverse Effects of Proton Pump Inhibitors
    Ament, Paul W.
    Dicola, Daniel B.
    James, Mary E.
    AMERICAN FAMILY PHYSICIAN, 2012, 86 (01) : 66 - 70
  • [46] Problems Associated with Deprescribing of Proton Pump Inhibitors
    Helgadottir, Holmfridur
    Bjornsson, Einar S.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (21)
  • [47] Proton Pump Inhibitors: A Better Prescription is Needed
    Khara, Harshit S.
    Pitchumoni, C. S.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (06) : 597 - 598
  • [48] Proton pump inhibitors for upper gastrointestinal bleeding
    Kherad, Omar
    Restellini, Sophie
    Martel, Myriam
    Barkun, Alan
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2019, 42-43
  • [49] Combining aspirin and proton pump inhibitors: for whom the warning bell tolls?
    Wurtz, Morten
    Grove, Erik Lerkevang
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2012, 8 (09) : 1051 - 1055
  • [50] Proton Pump Inhibitors and Dementia: Deciphering the Data
    Moayyedi, Paul
    Lewis, Maxine A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 (12) : 1809 - 1811